4//SEC Filing
Cormack Scott Daniel 4
Accession 0001209191-17-052370
CIK 0000949858other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 2:28 PM ET
Size
5.9 KB
Accession
0001209191-17-052370
Insider Transaction Report
Form 4
Cormack Scott Daniel
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2017-09-08$3.09/sh−1,491$4,607→ 14,810 total
Holdings
- 9,685(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]Represents shares of common stock that have been withheld by the issuer to satisfy its income tax withholding obligations in connection with the net settlement of restricted stock units reported by the reporting holder on August 3, 2017 in connection with the consummation of the merger on August 1, 2017 between OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. and does not represent a sale by the reporting person.
Documents
Issuer
ACHIEVE LIFE SCIENCES, INC.
CIK 0000949858
Entity typeother
Related Parties
1- filerCIK 0001442675
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 2:28 PM ET
- Size
- 5.9 KB